您的购物车当前为空
别名 塞替匹仑, KYTH-105, ACT-129968
Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 132 | In Stock | |
| 5 mg | ¥ 198 | In Stock | |
| 10 mg | ¥ 278 | In Stock | |
| 25 mg | ¥ 446 | In Stock | |
| 50 mg | ¥ 693 | In Stock | |
| 100 mg | ¥ 1,090 | In Stock | |
| 200 mg | ¥ 1,560 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 253 | In Stock |
Setipiprant 相关产品
| 产品描述 | Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells. |
| 靶点活性 | DP1 (human):1290 nM, EP2:2600 nM, CRTH2:6.0 nM |
| 别名 | 塞替匹仑, KYTH-105, ACT-129968 |
| 分子量 | 402.42 |
| 分子式 | C24H19FN2O3 |
| CAS No. | 866460-33-5 |
| Smiles | C(C(O)=O)N1C2=C(C=3C1=CC=C(F)C3)CN(C(=O)C=4C5=C(C=CC4)C=CC=C5)CC2 |
| 密度 | 1.37 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (111.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.97 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容